Next Article in Journal / Special Issue
Correction: de Melo et al. SARS-CoV-2 Spike Protein and Long COVID—Part 1: Impact of Spike Protein in Pathophysiological Mechanisms of Long COVID Syndrome. Viruses 2025, 17, 617
Previous Article in Journal
Advanced Strategies Against SARS-CoV-2 Variants and Future Emerging Virus Outbreaks
Previous Article in Special Issue
High-Fidelity and Cost-Effective Engineering of SARS-CoV-2
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Viruses
Volume 18
Issue 1
10.3390/v18010003
viruses-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Correction to Viruses 2025, 17(5), 619.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: de Melo et al. SARS-CoV-2 Spike Protein and Long COVID—Part 2: Understanding the Impact of Spike Protein and Cellular Receptor Interactions on the Pathophysiology of Long COVID Syndrome. Viruses 2025, 17, 619

by
Bruno Pereira de Melo
1,†,
Jhéssica Adriane Mello da Silva
1,†,
Mariana Alves Rodrigues
1,†,
Julys da Fonseca Palmeira
1,
Angélica Amorim Amato
2,
Gustavo Adolfo Argañaraz
1 and
Enrique Roberto Argañaraz
1,*
1
Laboratory of Molecular Neurovirology, Department of Pharmacy, Faculty of Health Science, University of Brasília, Brasília 70910-900, DF, Brazil
2
Laboratory of Molecular Pharmacology, Faculty of Health Science, University of Brasília, Brasilia 70910-900, DF, Brazil
*
Author to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Viruses 2026, 18(1), 3; https://doi.org/10.3390/v18010003
Submission received: 5 December 2025 / Accepted: 9 December 2025 / Published: 19 December 2025
(This article belongs to the Special Issue Viral RNA and Its Interaction with the Host)
Versions Notes

Error in Funding

In the original publication [1], the funding from the Federal District Research Support Foundation (FAPDF), DPI/BCE 01/2025, and the Bench Amendment, No. 7108001, was not included. The correct funding information should be as follows:
“This study received financial support from the Federal District Research Support Foundation (FAPDF), DPI/BCE 01/2025, and through Bench Amendment No. 7108001.”
The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. de Melo, B.P.; da Silva, J.A.M.; Rodrigues, M.A.; Palmeira, J.d.F.; Amato, A.A.; Argañaraz, G.A.; Argañaraz, E.R. SARS-CoV-2 Spike Protein and Long COVID—Part 2: Understanding the Impact of Spike Protein and Cellular Receptor Interactions on the Pathophysiology of Long COVID Syndrome. Viruses 2025, 17, 619. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

de Melo, B.P.; da Silva, J.A.M.; Rodrigues, M.A.; Palmeira, J.d.F.; Amato, A.A.; Argañaraz, G.A.; Argañaraz, E.R. Correction: de Melo et al. SARS-CoV-2 Spike Protein and Long COVID—Part 2: Understanding the Impact of Spike Protein and Cellular Receptor Interactions on the Pathophysiology of Long COVID Syndrome. Viruses 2025, 17, 619. Viruses 2026, 18, 3. https://doi.org/10.3390/v18010003

AMA Style

de Melo BP, da Silva JAM, Rodrigues MA, Palmeira JdF, Amato AA, Argañaraz GA, Argañaraz ER. Correction: de Melo et al. SARS-CoV-2 Spike Protein and Long COVID—Part 2: Understanding the Impact of Spike Protein and Cellular Receptor Interactions on the Pathophysiology of Long COVID Syndrome. Viruses 2025, 17, 619. Viruses. 2026; 18(1):3. https://doi.org/10.3390/v18010003

Chicago/Turabian Style

de Melo, Bruno Pereira, Jhéssica Adriane Mello da Silva, Mariana Alves Rodrigues, Julys da Fonseca Palmeira, Angélica Amorim Amato, Gustavo Adolfo Argañaraz, and Enrique Roberto Argañaraz. 2026. "Correction: de Melo et al. SARS-CoV-2 Spike Protein and Long COVID—Part 2: Understanding the Impact of Spike Protein and Cellular Receptor Interactions on the Pathophysiology of Long COVID Syndrome. Viruses 2025, 17, 619" Viruses 18, no. 1: 3. https://doi.org/10.3390/v18010003

APA Style

de Melo, B. P., da Silva, J. A. M., Rodrigues, M. A., Palmeira, J. d. F., Amato, A. A., Argañaraz, G. A., & Argañaraz, E. R. (2026). Correction: de Melo et al. SARS-CoV-2 Spike Protein and Long COVID—Part 2: Understanding the Impact of Spike Protein and Cellular Receptor Interactions on the Pathophysiology of Long COVID Syndrome. Viruses 2025, 17, 619. Viruses, 18(1), 3. https://doi.org/10.3390/v18010003

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop